To determine the role of programmed death-ligand 1 (PD-L1) in myofibroblastic activation of hepatic stellate cells (HSCs), researchers disrupted PD-L1 of HSCs by shRNA or anti-PD-L1 antibody.
[Cell Reports]
7992332
{7992332:BBBBBBBB}
apa
50
1
171602
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/